Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study.

@article{Rautava2008SpecificPI,
  title={Specific probiotics in reducing the risk of acute infections in infancy--a randomised, double-blind, placebo-controlled study.},
  author={Samuli Rautava and Seppo Salminen and Erika Isolauri},
  journal={The British journal of nutrition},
  year={2008},
  volume={101 11},
  pages={
          1722-6
        }
}
A randomised, double-blind, placebo-controlled study was conducted to determine whether probiotics might be effective in reducing the risk of infections in infancy. Infants requiring formula before the age of 2 months were recruited from community well-baby clinics. Infant formula supplemented with the probiotics Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb-12 or placebo was administered daily until the age of 12 months. Incidence of early infections (before the age of 7 months) and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 94 CITATIONS, ESTIMATED 70% COVERAGE

FILTER CITATIONS BY YEAR

2009
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Treatment of acute otitis media with probiotics in otitis-prone children – a double-blind, placebo-controlled randomised study

K Hatakka, K Plomgren, S Pohjavuori
  • Clin Nutr
  • 2007
VIEW 1 EXCERPT